Our Team

Our team is focused on rigorous science and efficient development to accelerate the delivery of first-ever treatment options. We collaborate closely with leading scientists and experts in disease biology, and our backgrounds include the deep technical, discovery, and entrepreneurial experience essential for pharmaceutical development.

Team

  • Katie Planey, PhD, MBA

    Chief Executive Officer

  • Mark Forman, MD, PhD

    Chief Development Officer &
    Chief Medical Officer

  • Lewis Whitehead, PhD

    Senior Vice President of R&D, Computational Discovery

  • Vidhu Mathur, PhD

    Vice President of R&D, Preclinical Biology

  • Valarie Truax, PhD, MBA

    Vice President, Business Development and Corporate Strategy

  • Michael Robin

    Vice President, Program Management & Operations

  • Marcie Glicksman, PhD

    Acting Chief Scientific Officer

  • Shruti Arya, PhD

    Senior Scientist I

  • Racquel Bruton, BA

    Senior Director of Clinical Operations

  • Marcela Kokes, PhD

    Associate Director of R&D, Preclinical Biology

  • Vanessa Seawright, MS

    Research Associate II

  • Devi Supriya Korumilli, MS

    Research Associate

  • Linda Szabo, PhD

    Associate Director of Computational Biology

  • Andrew Carr, PhD

    Senior Scientist

  • Cody Aldaz, PhD

    Data Scientist II

  • Olivia Reidell, MS

    Associate Program Manager

  • Vanessa Rivas

    Chief of Staff

Advisors

  • Ambuj Singh, PhD

    Founder & Board Member, Acelot; UCSB Professor, Department of Computer Science, Biomolecular Science and Engineering

  • David Bleakman, PhD

    President, Drug Discovery Psychogenics; Former CSO, Eli Lilly Neuroscience; Former CSO, Redpin Therapeutics

  • Andrew Perlman, MD, PhD

    Co-founder & Managing Director, X37; Former EVP, Tularik; Former CEO, Innate Immune; Former Director of Clinical Development, Genentech

  • Mike Kavanaugh, MD, PhD

    CSO, Cytomx; Former CSO, Five Prime Therapeutics; Former VP, Novartis Vaccines & Diagnostics

  • Steve Doberstein, PhD

    Former Chief Scientist, Nektar Therapeutics; Former Senior R&D, XOMA Royalty; Former Senior R&D, Five Prime Therapeutics; Former Senior R&D, Xencor; Former Senior R&D, Exelixis

Our Cultural Values

Connect with us

329 Oyster Point Blvd, 3rd Floor
South San Francisco, CA 94080